Allena Pharmaceuticals Stock News

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) with the stream of -5.30% also noticed, India Rio Tinto Group (NYSE:RIO) encountered a rapid change of 0.18% in the last hour of Tuesdays trading session. The post Bright Trending Stock: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), Rio Tinto Group (NYSE:RIO) appeared first on Stocks Equity .

Allena Pharmaceuticals Inc (ALNA) shares closed today at 0.4% above its 52 week low of $0.46, giving the company a market cap of $39M. The stock is currently down 19.2% year-to-date, down 65.5% over the past 12 months, and down 95.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 58.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 533.5% The company's stock price performance over the past 12 months lags the peer average by 114.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Allena Pharmaceuticals: A Double [Or More] Or Kaput In The Next 90 Days

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Liquidia Appoints Pharma Industry Veteran Roger Jeffs As CEO Liquidia Corporation (NASDAQ: LQDA) annou

NEWTON, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or the “Company”), a late-stage biopharmaceutical company deploying its novel oral biol

Allena Pharmaceuticals Inc (NASDAQ: ALNA) posted data from the first cohort of the Phase 2 trial (Study 201) evaluating ALLN-346 for hyperuricemia and gout in advanced chronic kidney disease (CKD)

The stock price of Allena Pharmaceuticals Inc (NASDAQ: ALNA) increased by over 55% pre-market today. This is why it happened.

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) with the stream of -0.41% also noticed, India Galiano Gold Inc. (AMEX:GAU) encountered a rapid change of 0.63% in the last hour of Thursdays trading session. The post Traders should divert their intention on this Stock: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), Galiano Gold Inc. (AMEX:GAU) appeared first on Stocks Equity .

Zacks Investment Research upgraded shares of Allena Pharmaceuticals (NASDAQ:ALNA) from a hold rating to a buy rating in a research report sent to investors on Tuesday, Zacks.com reports. The brokerage currently has $0.75 price target on the stock. According to Zacks, Allena Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in developing and commercializing oral []

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) with the stream of -2.97% also noticed, India New Gold Inc. (AMEX:NGD) encountered a rapid change of -5.56% in the last hour of Tuesdays trading session. The post Traders cant Passover this Stock: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), New Gold Inc. (AMEX:NGD) appeared first on Stocks Equity .

State Street Corp bought a new position in shares of Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 34,258 shares of the companys stock, valued at approximately $45,000. State Street Corp owned 0.06% of Allena Pharmaceuticals at the end of []

Wall Street brokerages expect that Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) will announce earnings of ($0.15) per share for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Allena Pharmaceuticals earnings. The highest EPS estimate is ($0.13) and the lowest is ($0.17). Allena Pharmaceuticals reported earnings of ($0.24) per share in the []

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) with the stream of -4.74% also noticed, India Northern Dynasty Minerals Ltd. (AMEX:NAK) encountered a rapid change of -3.89% in the last hour of Fridays trading The post Stock Views And Recommendations: Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), Northern Dynasty Minerals Ltd. (AMEX:NAK) appeared first on Stocks Equity .

Zacks Investment Research lowered shares of Allena Pharmaceuticals (NASDAQ:ALNA) from a buy rating to a hold rating in a research report report published on Thursday morning, Zacks.com reports. According to Zacks, Allena Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic []